Research Paper Volume 14, Issue 11 pp 4755—4768

LINC00094/miR-19a-3p/CYP19A1 axis affects the sensitivity of ER positive breast cancer cells to Letrozole through EMT pathway

class="figure-viewer-img"

Figure 5. Overexpression of LINC00094 affects IC50 of breast cancer cells to Letrozole. (A) The cell healing rate at 0 hours and 72 hours was measured by scratch assay with the scale of 100 μm. The experiment was repeated 3 times. **P<0.01, ****P<0.0001. (B) Transwell assay was performed to detect the effect of LINC00094 overexpression on the mobility of breast cancer cells, 20× microscope field, and the experiment was repeated 3 times. ****P<0.0001. (C) Cell clonal formation assay was performed to detect the effect of overexpression of LINC00094 on the colony formation of breast cancer cells. The experiment was repeated for 3 times.****P<0.0001. (D) CCK-8 was used to detect cell activity, and each group had 3 repeated wells.**P<0.01. (E) Graphpad Prism calculated IC50 of MCF-7 and BT-474 cells against Letrozole. ****P<0.0001.